(adventitious)
4,674 results
  • Regulatory Pathways of the Maturation-Related Decline in Adventitious Root Formation in Forest Tree Species. [Review]
    Plants (Basel). 2026 Jul 02; 15(13).Cordeiro D, Pizarro A, Díaz-Sala CP
  • Vegetative propagation is widely used in forest plantations to propagate elite genotypes with traits of economic or ecological interest. However, the loss of the ability to form adventitious roots is a dramatic effect of tree age and maturation and represents a major limitation for the clonal propagation of high-quality genotypes. This review describes the evolution of our understanding-from the …
  • Bioreactor Technology for Medicinal Plant In Vitro Cultures: Systems, Applications, and Future Perspectives. [Review]
    Biology (Basel). 2026 Jun 27; 15(13).Zhang S, Ma M, … Wei KB
  • Bioreactor technology for medicinal plants provides a controllable platform for the conservation of rare and endangered resources, the production of high-value-added active ingredients, and green manufacturing of traditional Chinese medicine. Focusing on in vitro culture systems of medicinal plants, this article systematically reviews the application progress of stirred-tank, airlift, bubble colu…
  • Nitrogen Deficiency Outperforms Water Stress in Triggering Strigolactone-Dependent Responses in Maize. [Journal Article]
    Physiol Plant. 2026 Jul-Aug; 178(4):e70987.Buzzicotti L, Camilletti C, … Quaggiotti SPP
  • Strigolactones (SLs) modulate multiple aspects of plant development and stress physiology. This study investigated their role in maize response to abiotic stress by comparing an SL-biosynthesis mutant (zmccd8) with wild-type (WT) seedlings grown for 4 weeks in vermiculite under nutrient and water limitation. Plant growth, time-course pigment accumulation, targeted gene expression, and root transc…
  • Demonstration of nanofiltration-based virus safety for AAV manufacturing using model viruses. [Journal Article]
    Biotechnol Prog. 2026 Jul 07; :e88541. [Online ahead of print]Buesing B, Igi T, Strauss DBP
  • Virus safety for biopharmaceutical products has been a well-established concern for several decades. While various virus reduction steps have been identified and implemented for traditional plasma-derived and monoclonal antibody products, there are various challenges to achieving the same virus safety in emerging gene therapy products. Virus removal filtration, or nanofiltration, has proven diffi…